159 related articles for article (PubMed ID: 3296201)
21. Analysis of cell surface antigen on neoplastic lymphocytes by the use of anti-human brain serum.
Kawata M; Ohmori K; Tanabe E; Okumura K; Takamizawa H; Tada T
Gan; 1980 Dec; 71(6):816-24. PubMed ID: 6974114
[TBL] [Abstract][Full Text] [Related]
22. Immunologic and cytochemical characterization of lymphoreticular malignancies.
Grogan TM; Hicks MJ; Jolley C
Ariz Med; 1981 Jul; 38(7):524-8. PubMed ID: 6168251
[No Abstract] [Full Text] [Related]
23. Studies with multiple markers on malignant lymphomas and lymphoid leukemias.
Watanabe S; Shimosato Y; Shimoyama M; Minato K
Cancer; 1982 Dec; 50(11):2372-82. PubMed ID: 6982748
[TBL] [Abstract][Full Text] [Related]
24. Differentiation antigens associated with hairy cell leukemia.
Posnett DN; Marboe CC
Semin Oncol; 1984 Dec; 11(4):413-5. PubMed ID: 6438802
[No Abstract] [Full Text] [Related]
25. Nonspecific cross-reacting antigen in normal and leukemic myeloid cells and serum of leukemic patients.
Wahren B; Gahrton G; Hammarström S
Cancer Res; 1980 Jun; 40(6):2039-44. PubMed ID: 6929221
[No Abstract] [Full Text] [Related]
26. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
27. [Analysis and classification of leukemia and malignant lymphoma cells using monoclonal antibodies].
Uede T; Kikuchi K
Nihon Rinsho; 1983; 41(4):815-20. PubMed ID: 6350650
[No Abstract] [Full Text] [Related]
28. Identification of the human T cell lymphoma virus in B cell lines established from patients with adult T cell leukemia.
Mann DL; Clark J; Clarke M; Reitz M; Popovic M; Franchini G; Trainor CD; Strong DM; Blattner WA; Gallo RC
J Clin Invest; 1984 Jul; 74(1):56-62. PubMed ID: 6330177
[TBL] [Abstract][Full Text] [Related]
29. Marker profiles of human leukemia and lymphoma cell lines.
Minowada J; Koshiba H; Sagawa K; Kubonishi I; Lok MS; Tatsumi E; Han T; Srivastava BI; Ohnuma T
J Cancer Res Clin Oncol; 1981; 101(1):91-100. PubMed ID: 6974176
[TBL] [Abstract][Full Text] [Related]
30. HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.
Dörken B; Moldenhauer G; Pezzutto A; Schwartz R; Feller A; Kiesel S; Nadler LM
J Immunol; 1986 Jun; 136(12):4470-9. PubMed ID: 3086431
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic and functional characterization of human malignant T cells.
Harden EA; Haynes BF
Semin Hematol; 1985 Jan; 22(1):13-26. PubMed ID: 3918348
[TBL] [Abstract][Full Text] [Related]
32. Leukemic cell phenotypes in man: relationship to 'target' cells for leukemogenesis and differentiation linked gene expression.
Greaves MF
Haematol Blood Transfus; 1979; 23():335-45. PubMed ID: 317474
[No Abstract] [Full Text] [Related]
33. The use of monoclonal antibodies for purging autologous bone marrow in the lymphoid malignancies.
Macintyre EA
Clin Haematol; 1986 Feb; 15(1):249-67. PubMed ID: 3516492
[No Abstract] [Full Text] [Related]
34. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4).
Hashimi L; Wang CY; Al-Katib A; Koziner B
Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065
[TBL] [Abstract][Full Text] [Related]
35. Immune markers in hematologic malignancies.
Vaickus L; Ball ED; Foon KA
Crit Rev Oncol Hematol; 1991 Dec; 11(4):267-97. PubMed ID: 1777090
[TBL] [Abstract][Full Text] [Related]
36. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.
Nadler LM; Anderson KC; Marti G; Bates M; Park E; Daley JF; Schlossman SF
J Immunol; 1983 Jul; 131(1):244-50. PubMed ID: 6408173
[TBL] [Abstract][Full Text] [Related]
37. The induction of Leu-1 antigen expression in human malignant and normal B cells by phorbol myristic acetate (PMA).
Miller RA; Gralow J
J Immunol; 1984 Dec; 133(6):3408-14. PubMed ID: 6436381
[TBL] [Abstract][Full Text] [Related]
38. The analysis of lymphoid subpopulations in normal and malignant tissues by immunofluorescence techniques.
Janossy G; Thomas JA; Pizzolo G
J Cancer Res Clin Oncol; 1981; 101(1):1-11. PubMed ID: 6456270
[TBL] [Abstract][Full Text] [Related]
39. Immunologic markers for classification of leukemias and non-Hodgkin lymphomas.
Thierfelder S; Rodt H; Thiel E; Hoffmann-Fezer G; Netzel B; Haas RJ; Wündisch GF; Bender-Götze C
Recent Results Cancer Res; 1979; 69():41-8. PubMed ID: 382307
[No Abstract] [Full Text] [Related]
40. Distribution of a hematopoietic-specific differentiation antigen of K562 cells in the human myeloid and lymphoid cell lineages.
Clarke BJ; Liao SK; Leeds C; Soamboonsrup P; Neame PB
Cancer Res; 1987 Aug; 47(16):4254-9. PubMed ID: 3475169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
